Martin Hénault

1.1k total citations
15 papers, 431 citations indexed

About

Martin Hénault is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Martin Hénault has authored 15 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Immunology and 3 papers in Oncology. Recurrent topics in Martin Hénault's work include Immune Response and Inflammation (4 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (2 papers). Martin Hénault is often cited by papers focused on Immune Response and Inflammation (4 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (2 papers). Martin Hénault collaborates with scholars based in United States, Canada and China. Martin Hénault's co-authors include Raymund R. Razonable, Linda N. Lee, H L Watson, Carlos V. Payá, Marc Hild, Caroline Gubser Keller, Gregory McAllister, Daniel Ho, Pierre Farmer and Nadezda Kryuchkova-Mostacci and has published in prestigious journals such as Nature Communications, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Martin Hénault

15 papers receiving 431 citations

Peers

Countries citing papers authored by Martin Hénault

Since Specialization

Citations

This map shows the geographic impact of Martin Hénault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Hénault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Hénault more than expected).

Fields of papers citing papers by Martin Hénault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Hénault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Hénault. The network helps show where Martin Hénault may publish in the future.

Co-authorship network of co-authors of Martin Hénault

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Hénault. A scholar is included among the top collaborators of Martin Hénault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Hénault. Martin Hénault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	An IMiD-inducible degron provides reversible regulation for chimeric antigen receptor expression and activity 2021 ·Cell chemical biology ·Seth Carbonneau, (unknown), Liaomin Peng, (unknown), Dominik Hainzl, Martin Hénault, (unknown), (unknown), Janine Shulok, John A. Tallarico, (unknown), Jennifer L. Brogdon, Glenn Dranoff, James E. Bradner, Marc Hild, Carla P. Guimarães	4
2	An IMiD-inducible degron provides reversible regulation for chimeric antigen receptor expression and activity 2020 ·Cell chemical biology ·Seth Carbonneau, Sujata Sharma, Liaomin Peng, (unknown), Dominik Hainzl, Martin Hénault, (unknown), (unknown), Janine Shulok, John A. Tallarico, Jeff Porter, Jennifer L. Brogdon, Glenn Dranoff, James E. Bradner, Marc Hild, (unknown)	31
3	DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery 2018 ·Nature Communications ·Chaoyang Ye, Daniel Ho, Marilisa Neri, (unknown), (unknown), Ranjit Randhawa, Martin Hénault, Nadezda Kryuchkova-Mostacci, Pierre Farmer, Steffen Renner, Robert J. Ihry, Leandra Mansur, Caroline Gubser Keller, Gregory McAllister, Marc Hild, Jeremy L. Jenkins, Ajamete Kaykas	135
4	An activity-based probe for high-throughput measurements of triacylglycerol lipases 2011 ·Analytical Biochemistry ·John Tam, Martin Hénault, Lianhai Li, Zhaoyin Wang, Anthony W. Partridge, Roman A. Melnyk	12
5	Resorufin Butyrate as a Soluble and Monomeric High-Throughput Substrate for a Triglyceride Lipase 2011 ·SLAS DISCOVERY ·Vincent Lam, Martin Hénault, Karine Khougaz, (unknown), Marc Ouellet, Roman A. Melnyk, Anthony W. Partridge	5
6	Discovery of Novel P2Y14 Agonist and Antagonist Using Conventional and Nonconventional Methods 2011 ·SLAS DISCOVERY ·Martine Hamel, Martin Hénault, (unknown), Nicolas Morin, Christopher I. Bayly, Kathryn Skorey, Alex G. Therien, Joseph A. Mancini, Christine Brideau, Stacia Kargman	13
7	Synthesis and evaluation of a new series of Neuropeptide S receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey Y. Melamed, (unknown), Nathan R. Kett, Anthony L. Gotter, Victor N. Uebele, Duane R. Reiss, Cindra Condra, Christine Fandozzi, Laura S. Lubbers, Blake A. Rowe, Georgia B. McGaughey, Martin Hénault, Rino Stocco, John J. Renger, George D. Hartman, Mark T. Bilodeau, B. Wesley Trotter	21
8	Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y14 2010 ·Bioorganic & Medicinal Chemistry Letters ·Joël Robichaud, Jean‐François Fournier, Sébastien Gagné, Jacques Yves Gauthier, Martine Hamel, Yongxin Han, Martin Hénault, Stacia Kargman, Jean-François Lévesque, Yaël Mamane, Joseph A. Mancini, Nicolas Morin, (unknown), Jin Wu, W. Cameron Black	44
9	Tricyclic imidazole antagonists of the Neuropeptide S Receptor 2010 ·Bioorganic & Medicinal Chemistry Letters ·B. Wesley Trotter, Kausik K. Nanda, Peter J. Manley, Victor N. Uebele, Cindra Condra, Anthony L. Gotter, Karsten Menzel, Martin Hénault, Rino Stocco, John J. Renger, George D. Hartman, Mark T. Bilodeau	19
10	Design, synthesis, and evaluation of novel 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective CXCR2 chemokine receptor antagonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Yinhui Liu, Hongmei Wang, (unknown), Hao Wu, (unknown), Angela Wong, Shu‐Hui Chen, Ge Li, (unknown), Nicole Sawyer, François G. Gervais, Martin Hénault, Stacia Kargman, Leanne L. Bedard, Yongxin Han, (unknown), Robert B. Lobell, David M. Stout	13
11	Stimulation of toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines 2005 ·Toxicology and Applied Pharmacology ·Raymund R. Razonable, Martin Hénault, (unknown)	37
12	The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides 2005 ·Journal of Immunological Methods ·Martin Hénault, Linda N. Lee, Glenn F. Evans, Steven H. Zuckerman	21
13	Nystatin Induces Secretion of Interleukin (IL)-1β, IL-8, and Tumor Necrosis Factor Alpha by a Toll-Like Receptor-Dependent Mechanism 2005 ·Antimicrobial Agents and Chemotherapy ·Raymund R. Razonable, Martin Hénault, H L Watson, Carlos V. Payá	24
14	Secretion of Proinflammatory Cytokines and Chemokines during Amphotericin B Exposure Is Mediated by Coactivation of Toll-Like Receptors 1 and 2 2005 ·Antimicrobial Agents and Chemotherapy ·Raymund R. Razonable, Martin Hénault, Linda N. Lee, Carmen Laethem, Paul A. Johnston, H L Watson, Carlos V. Payá	51
15	Identification and Characterization of Streptococcus pneumoniae Ffh, a Homologue of SRP54 Subunit of Mammalian Signal Recognition Particle 2002 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Laura Campo, Martin Hénault, H L Watson, (unknown), Sheng-Bin Peng	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact